INmune Bio, Inc. (INMB)
1.445
+0.04
(+2.48%)
USD |
NASDAQ |
May 21, 16:00
1.445
0.00 (0.00%)
After-Hours: 17:13
INmune Bio Shareholders Equity (Quarterly) : 19.62M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| PDS Biotechnology Corp. | 3.893M |
| Sangamo Therapeutics, Inc. | -18.96M |
| ACADIA Pharmaceuticals, Inc. | 1.248B |
| Alnylam Pharmaceuticals, Inc. | 1.075B |
| Amgen, Inc. | 9.19B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 25.82M |
| Total Liabilities (Quarterly) | 6.194M |
| Debt to Equity Ratio | 0.0769 |
| Current Ratio | 4.236 |
| Net Debt Paydown Yield | -0.75% |